Title: Anvari E, et al. The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL/6 mice. Free Radic Res. 2015;49(11):1308-18.
308833-03-6
353478-78-1
496777-49-2
326889-85-4
60442-43-5
868965-15-5
1401034-19-2 | AMG 925 HCl | AA01EO59 | MFCD31657448
828288-98-8 | Asp-AMS | AA01EOBE | MFCD31746899
1383718-29-3 | NecroX-5 | AA01EOGB
204512-90-3 | Tecadenoson | AA01EOLR | MFCD08690887
942123-43-5 | Inarigivir soproxil | AA01EOQ5 | MFCD31715418
877618-79-6 | N-(6-methyl-2-benzothiazolyl)-2-[[3,4,6,7-tetrahydro-4-oxo-3-(phenylmethyl)thieno[3,2-d]pyrimidin-2-yl]thio]-acetamide | AA01EP09 | MFCD05963653
3892-78-2 | 10-[3-[4-(2-chloroethyl)-1-piperazinyl]propyl]-2-(trifluoromethyl)-10H-phenothiazinedihydrochloride | AA01EPAN
1807-12-1 | N-(4-methylphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide,monohydrochloride | AA01EPHW | MFCD06411235
1675201-90-7 | 1-[[3-bromo-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-piperidinecarboxylicacid | AA01EPNH | MFCD31714164
1465-20-9 | phenyl[1-(2-phenylethyl)-4-piperidinyl]-carbamicacid,ethylester | AA01EPUC
